Chris Williams
Vermogen: 41 729 $ op 31-07-2026
Vermogen: 41 729 $ op 31-07-2026
Chris Williams is Chief Business Development Officer & Senior VP at Autolus Therapeutics Plc since 2024.
Former roles include Non-Executive Director at Autolus Ltd. and Director at Orchard Therapeutics (Europe) Ltd. Education includes graduate studies at Imperial College London and undergraduate studies at the University of Cardiff.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 28.006 ( 0,02% ) | 41 729 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 01-02-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Directeur/Bestuurslid | - |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau